SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-004128
Filing Date
2023-01-09
Accepted
2023-01-09 07:07:57
Documents
14
Period of Report
2023-01-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d422387d8k.htm   iXBRL 8-K 25919
2 EX-99.1 d422387dex991.htm EX-99.1 15791
6 GRAPHIC g422387g0108021238694.jpg GRAPHIC 2701
  Complete submission text file 0001193125-23-004128.txt   177847

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA alvr-20230109.xsd EX-101.SCH 2850
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE alvr-20230109_lab.xml EX-101.LAB 18737
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alvr-20230109_pre.xml EX-101.PRE 11707
8 EXTRACTED XBRL INSTANCE DOCUMENT d422387d8k_htm.xml XML 3509
Mailing Address 1100 WINTER STREET WALTHAM MA 02451
Business Address 1100 WINTER STREET WALTHAM MA 02451 (617) 433-2605
Allovir, Inc. (Filer) CIK: 0001754068 (see all company filings)

IRS No.: 831971007 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39409 | Film No.: 23516532
SIC: 2836 Biological Products, (No Diagnostic Substances)